Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
8Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Adagene Inc. (ADAG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
3Distinct source URLs
4High confidence
0.735Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Adagene Inc. Suppliers
Ticker
Name
Confidence
Evidence
SNYNF
Sanofi
72%
The Sanofi Agreement will remain effective until the expiration of the defined royalty on a product-by-product and country-by-country basis, unless terminated earlier with cause or by mutual agreemen…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ADAG graph: The Sanofi Agreement will remain effective until the expiration of the defined royalty on a product-by-product and c…
Reciprocal relationship from JANX graph: Reciprocal relationship from ADAG graph: Reciprocal relationship from JANX graph: Reciprocal relationship from ADAG graph: Reciprocal relationship from JANX g…
Reciprocal relationship from MRK graph: Reciprocal relationship from ADAG graph: Reciprocal relationship from MRK graph: Reciprocal relationship from ADAG graph: us to further compliance risk. Given …
us to further compliance risk. Given the variability and evolving state of these laws, we face uncertainty as to the exact interpretation of the new requirements, and we may be unsuccessful in implem…
SNYNF
Sanofi
72%
The Sanofi Agreement will remain effective until the expiration of the defined royalty on a product-by-product and country-by-country basis, unless terminated earlier with cause or by mutual agreemen…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ADAG graph: The Sanofi Agreement will remain effective until the expiration of the defined royalty on a product-by-product and c…
EXPORTING-HUMAN-GENETIC-RESOURCES
EXPORTING-HUMAN-GENETIC-RESOURCES
62%
eric drug application and imported drug application. Drugs are classified into chemical drugs, biological products and traditional Chinese medicine or natural drugs. When Phases I, II and III clinica…
HUMAN-GENETIC-RESOURCES
HUMAN-GENETIC-RESOURCES
62%
eric drug application and imported drug application. Drugs are classified into chemical drugs, biological products and traditional Chinese medicine or natural drugs. When Phases I, II and III clinica…
TAKING-SUCH-RESOURCES
TAKING-SUCH-RESOURCES
62%
eric drug application and imported drug application. Drugs are classified into chemical drugs, biological products and traditional Chinese medicine or natural drugs. When Phases I, II and III clinica…
UNITED-STATES-ADAGENE-INC
UNITED-STATES-ADAGENE-INC
62%
se, if approved; ● future strategic arrangements and/or collaborations and the potential benefits of such arrangements; ● our anticipated use of our existing resources and the proceeds from our initi…
Adagene Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ADAG-DEBT-7494
Warrants outstanding: 1000000
90%
xbrl warrant detail from xbrl 2025-12-31.
ADAG-DEBT-7495
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
ADAG-DEBT
Debt stack $6.1M
90%
Market cache reports total debt of $6.1M.
Adagene Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Adagene Inc..
Adagene Inc. Ownership
Holder
Name
Confidence
Evidence
ADAG-OWNER-HSG-HOLDING-LTD
HSG Holding Ltd
90%
13F overlay lists HSG Holding Ltd as top holder; 26 tracked holders.
